LATEST
GTCR agreed to acquire CCC Intelligent SolutionsnewEQT agreed to acquire StockbridgenewProofpoint agreed to acquire VaronisnewMubadala Capital acquired Clear Channel OutdoorIthaca Holdings agreed to acquire BumblePenta Fine Ingredients acquired SynerzineHexagon agreed to acquire RocscienceSRS Acquiom / PantaraiSpaceX agreed to acquire nationwide 800 MHz spectrum portfolioAEA Investors acquired RensaWittington Investments agreed to acquire BootsEurazeo / MIYA Water: majority stake
Open App
Agreement signedPublished 10 Jul 2026

VYNE Therapeutics Inc. /
Yarrow Bioscience, Inc.

VYNE agrees to merge with Yarrow Bioscience

Buy side: VYNE Therapeutics Inc.
Buy sideVYNE Therapeutics Inc.
Target: Yarrow Bioscience, Inc.
TargetYarrow Bioscience, Inc.
VYNE Therapeutics Inc. · 10 Jul 2026Source
See the source
Follow VYNE Therapeutics Inc. Follow Yarrow Bioscience, Inc.
Buy side: VYNE Therapeutics Inc.
Buy sideVYNE Therapeutics Inc.
Target: Yarrow Bioscience, Inc.
TargetYarrow Bioscience, Inc.
01 / BuyerVYNE Therapeutics Inc.
02 / TargetYarrow Bioscience, Inc.
Source for the buyer and target: VYNE Therapeutics Inc.

For the buyer and target.

“NEW YORK , July 10, 2026 – VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has declared a special cash dividend (the “Cash Dividend”) in connection with the previously announced merger (the “Merger”) with Yarrow Bioscience, Inc. (“Yarrow”) pursuant to the Agreement and Plan of Merger and Reorganization, dated December 17, 2025 (as amended, the “Merger Agreement”).”

Published 10 Jul 2026

Open the source
01

What happened

VYNE Therapeutics Inc. agreed to combine with Yarrow Bioscience under a merger agreement dated Dec. 17, 2025. Yarrow would become a wholly owned subsidiary of VYNE after the merger takes effect. [01]

VYNE declared a special cash dividend tied to the deal, estimated at $16.5 million, or $0.38 per share. Payment is conditioned on closing, which is expected on or about July 24, 2026, subject to stockholder approval at a special meeting on July 16, 2026. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · VYNE Therapeutics Inc.

VYNE agrees to merge with Yarrow Bioscience

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Announced

    “VYNE agrees to merge with Yarrow Bioscience VYNE Therapeutics Inc. agreed to combine with Yarrow Bioscience under a merger agreement dated Dec. 17, 2025”

    Open the source

  2. Published by VYNE Therapeutics Inc.

    The source this page is built from.

    Open the source

  3. Also stated

    “Payment is conditioned on closing, which is expected on or about July 24, 2026, subject to stockholder approval at a special meeting on July 16, 2026”

    Open the source

  4. Expected close

    “Payment is conditioned on closing, which is expected on or about July 24, 2026, subject to stockholder approval at a special meeting on July 16, 2026”

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.

04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 2 firms · 0 peopleHover a name to see how it connects
This dealVYNE Therapeutics Inc. / Yarrow Bioscience, Inc.Agreement signed · Published 10 Jul 2026
BuyerVYNE Therapeutics Inc.TargetYarrow Bioscience, Inc.
This dealVYNE Therapeutics Inc. / Yarrow Bioscience, Inc.

Agreement signed · VYNE Therapeutics Inc. / Yarrow Bioscience, Inc. deal (Agreement signed, published 10 Jul 2026).

Announced 17 Dec 2025
Timeline
  1. Announced
  2. Published by VYNE Therapeutics Inc.
  3. Also stated
  4. Expected close
Hover or tap a name to see how it connects, and when
Deal Web as a list